1 / 8

Clinical Perspectives: Muscular Dystrophy Case Study

Clinical Perspectives: Muscular Dystrophy Case Study. Alison Skinner RCPath Self Help Course 6 th October 2008. Pedigree. Linkage Analysis 1. Linkage Analysis 2. Further Testing. Sent for dystrophin point mutation analysis No mutations identified

allegra-moses
Download Presentation

Clinical Perspectives: Muscular Dystrophy Case Study

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Perspectives:Muscular Dystrophy Case Study Alison Skinner RCPath Self Help Course 6th October 2008

  2. Pedigree

  3. Linkage Analysis 1

  4. Linkage Analysis 2

  5. Further Testing • Sent for dystrophin point mutation analysis • No mutations identified • FKRP screening was done due to clinical overlap • Patient is a compound heterozygote for c.826C>A (p.L276I) and c.1217A>C (p.Q406P)

  6. FKRP Report • “p.L276I has been seen numerous times and is very likely to be pathogenic” • “p.Q406P has not been reported previously and the clinical significance of this mutation is less certain. However it is a non-conservative amino acid substitution that occurs at an evolutionary conserved amino acid and is therefore likely to be pathogenic” • This result is consistent with a diagnosis of an FKRP-related muscular dystrophy

  7. Cascade Screening Normal p.L276I p.L276I p.L276I Normal p.L276I / p.Q406P

  8. FKRP Function

More Related